We serve Chemical Name:4-Chloro-N-(3,4-difluorophenyl)benzamide CAS:328262-13-1 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:4-Chloro-N-(3,4-difluorophenyl)benzamide
CAS.NO:328262-13-1
Synonyms:4-Chloro-N-(3,4-difluorophenyl)benzamide
Molecular Formula:C13H8ClF2NO
Molecular Weight:267.65900
HS Code:
Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:29.10000
Exact Mass:267.02600
LogP:3.94350
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 4-Chloro-N-(3,4-difluorophenyl)benzamide chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,4-Chloro-N-(3,4-difluorophenyl)benzamide physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,4-Chloro-N-(3,4-difluorophenyl)benzamide Use and application,4-Chloro-N-(3,4-difluorophenyl)benzamide technical grade,usp/ep/jp grade.
Related News: According to Plexxikon, GSK scientists were only able to make Tafinlar after talks with Plexxikon about a potential partnership; although those talks never turned into a licensing deal, GSK apparently channeled that information and created a rival drug. Oxidase, cytochrome (Tomicus n. CK-2004 strain P-LL3 host Pinusyunnanensis country China mitochondria-encoded gene COII subunit IIN-terminal fragment) manufacturers A nasal therapy, built upon on the application of a new engineered IgM antibody therapy for COVID-19, was more effective than commonly used IgG antibodies at neutralizing the COVID-19 virus in animal models, according to research recently published by The University of Texas Health Science Center at Houston (UTHealth), The University of Texas Medical Branch at Galveston (UTMB Health), the University of Houston, and IGM Biosciences, Inc. (Z)-9-iodo-1-(2-tetrahydropyranyloxy)non-8-ene suppliers Jan Vertommen, Senior Director, Commercial Development, Lonza, said, “Increasing our capabilities by adding mid-scale API manufacturing at our site in Nansha will benefit our customers, and especially the many global emerging biotech companies we partner with. N-(4-nitrophenyl)-N’-(6-chlorobenzothiazol-2-yl)urea vendor & factory.
